​

uniQure (QURE) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

QURE Stock Forecast

uniQure (QURE) stock forecast, based on 38 Wall Street analysts, predicts a 12-month average price target of $57.22, with a high of $80.00 and a low of $28.00. This represents a 24.39% increase from the last price of $46.00.

- $16 $32 $48 $64 $80 High: $80 Avg: $57.22 Low: $28 Last Closed Price: $46

QURE Stock Rating

uniQure stock's rating consensus is Buy, based on 38 Wall Street analysts. The breakdown includes 1 Strong Buy (2.63%), 32 Buy (84.21%), 5 Hold (13.16%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 38 5 32 1 Strong Sell Sell Hold Buy Strong Buy

QURE Price Target Upside V Benchmarks

TypeNameUpside
StockuniQure24.39%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts-829
Avg Price Target-$64.38$51.07
Last Closing Price$46.00$46.00$46.00
Upside/Downside-39.96%11.02%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Sep, 26291--12
Aug, 262101--13
Jul, 26292--13
Jun, 26184--13
May, 26184--13
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jul 30, 2026Barclays$60.00$40.0749.74%30.43%
Jun 29, 2026H.C. Wainwright$80.00$47.5168.39%73.91%
Jun 25, 2026Uy EarMizuho Securities$68.00$48.8539.20%47.83%
Jun 18, 2026RBC Capital$65.00$48.1634.97%41.30%
Jun 18, 2026Barclays$65.00$48.1634.97%41.30%
Jun 18, 2026Joseph SchwartzLeerink Partners$70.00$48.1645.35%52.17%
Jun 18, 2026Salveen RichterGoldman Sachs$46.00$48.16-4.49%-
Jun 17, 2026Cantor Fitzgerald$61.00$47.4028.69%32.61%
May 06, 2026Patrick TrucchioH.C. Wainwright$50.00$21.64131.05%8.70%
May 05, 2026Paul MatteisStifel Nicolaus$28.00$20.7834.74%-39.13%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jul 29, 2026Wolfe ResearchPeer PerformOutperformupgrade
Jun 18, 2026RBC CapitalOutperformOutperformhold
Jun 18, 2026BarclaysPositiveOverweightupgrade
Jun 18, 2026H.C. WainwrightBuyBuyhold
Jun 18, 2026Goldman SachsNeutralNeutralhold
Jun 17, 2026Cantor FitzgeraldNeutralOverweightupgrade
Jun 17, 2026BarclaysPositivePositivehold
May 06, 2026H.C. WainwrightBuyBuyhold
Apr 20, 2026Goldman SachsNeutralNeutralhold
Mar 09, 2026Wells FargoOverweightOverweightupgrade

Financial Forecast

EPS Forecast

$-15 $-8 $-1 $6 $13 $20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$7.17$-2.71$-6.47$-4.92$-3.46---
Avg Forecast$6.17$-3.75$-6.31$-4.08$-3.38$-2.65$0.24$1.59
High Forecast$19.18$-0.76$-5.52$-2.60$-2.04$-1.18$0.94$4.29
Low Forecast$0.81$-12.82$-6.79$-4.81$-4.08$-3.47$-1.77$0.02
Surprise %16.21%-27.73%2.54%20.59%2.37%---

Revenue Forecast

$0 $300M $600M $900M $1B $2B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$524.00M$106.48M$15.84M$27.12M$16.10M---
Avg Forecast$475.82M$30.57M$20.88M$41.03M$35.04M$115.19M$224.16M$426.50M
High Forecast$1.25B$87.54M$24.70M$87.71M$80.89M$265.96M$230.88M$984.69M
Low Forecast$157.60M$11.85M$17.22M$16.50M$8.45M$27.78M$217.44M$102.84M
Surprise %10.13%248.31%-24.11%-33.91%-54.05%---

Net Income Forecast

$-400M $-240M $-80M $80M $240M $400M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$329.59M$-126.79M$-308.48M$-239.56M$-198.97M---
Avg Forecast$278.41M$-158.89M$-308.48M$-176.70M$-157.36M$-121.56M$-54.56M$75.77M
High Forecast$386.84M$-120.98M$-234.86M$-124.03M$-97.07M$-56.14M$44.92M$204.69M
Low Forecast$169.98M$-196.81M$-382.09M$-229.37M$-194.66M$-165.31M$-84.60M$1.02M
Surprise %18.38%-20.20%-35.57%26.45%---

QURE Forecast FAQ

Is uniQure stock a buy?

uniQure stock has a consensus rating of Buy, based on 38 Wall Street analysts. The rating breakdown includes 1 Strong Buy, 32 Buy, 5 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that uniQure is a favorable investment for most analysts.

What is uniQure's price target?

uniQure's price target, set by 38 Wall Street analysts, averages $57.22 over the next 12 months. The price target range spans from $28 at the low end to $80 at the high end, suggesting a potential 24.39% change from the previous closing price of $46.

How does uniQure stock forecast compare to its benchmarks?

uniQure's stock forecast shows a 24.39% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for uniQure over the past three months?

  • September 2026: 16.67% Strong Buy, 75.00% Buy, 8.33% Hold, 0% Sell, 0% Strong Sell.
  • August 2026: 15.38% Strong Buy, 76.92% Buy, 7.69% Hold, 0% Sell, 0% Strong Sell.
  • July 2026: 15.38% Strong Buy, 69.23% Buy, 15.38% Hold, 0% Sell, 0% Strong Sell.

What is uniQure’s EPS forecast?

uniQure's average annual EPS forecast for its fiscal year ending in December 2026 is $-2.65, marking a -23.41% decrease from the reported $-3.46 in 2025. Estimates for the following years are $0.24 in 2027, and $1.59 in 2028.

What is uniQure’s revenue forecast?

uniQure's average annual revenue forecast for its fiscal year ending in December 2026 is $115.19M, reflecting a 615.57% increase from the reported $16.1M in 2025. The forecast for 2027 is $224.16M, and $426.5M for 2028.

What is uniQure’s net income forecast?

uniQure's net income forecast for the fiscal year ending in December 2026 stands at $-122M, representing a -38.90% decrease from the reported $-199M in 2025. Projections indicate $-54.563M in 2027, and $75.77M in 2028.